PerkinElmer Appoints Robert F. Friel As Chairman of the Board of Directors
Waltham, MA – PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, today announced that its board of directors has appointed the Company’s president and chief executive officer, Robert F. Friel, to the additional role of chairman of the board of directors. The announcement comes in conjunction with the Company’s annual shareholders meeting held on April 28, 2009. The appointment of Mr. Friel to chairman is part of PerkinElmer’s 2007 leadership succession plan designed to support the Company’s growth strategy and provide strong leadership continuity. Friel succeeds Gregory L. Summe, chairman since 1999, who did not stand for reelection.
“Rob’s leadership and deep understanding of PerkinElmer’s businesses, organization and entrepreneurial culture makes him ideally suited to lead the Company going forward,” said Summe. “I believe that PerkinElmer today has an executive management team in place that is well positioned to continue driving the global growth and profitability of the Company through providing greater value to customers worldwide.”
“Greg’s vision, commitment and strong leadership over the last decade have been instrumental in transforming PerkinElmer from a diversified company with an offering largely focused in government services, to a $2 billion global technology and health sciences leader,” said Friel. “We will leverage our strong operating foundation to continue expanding our human and environmental health businesses and broadening our footprint in emerging markets. We thank Greg for all of his contributions to the Company.”
Friel joined PerkinElmer in 1999 as chief financial officer and was appointed vice chairman and president of the Company’s Life and Analytical Sciences business in 2006. In 2007, Friel was appointed president and chief operating officer of the Company. He succeeded Mr. Summe as chief executive officer in 2008.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products decline or do not grow as anticipated; (2) global economic, political and other risks; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials, key components and supplies; (11) the manufacture and sale of products may expose us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with health care industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems or the failure to successfully implement new systems; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; (21) dividends we pay on our stock could be reduced or eliminated in the future; and (22) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

